Antonio Tauler
Psychiatry · Coral Gables, FLNPI 1851342844
Payments from drug & device makers
Across 638 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Johnson & Johnson$818
- Alkermes, Inc.$675
- Lundbeck LLC$625
- plus $4K from 17 others
What the payments were for
- Food & beverage$10,80599%
- Education$1111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 158 | $2,420 |
| Otsuka America Pharmaceutical, Inc. | 70 | $1,368 |
| Teva Pharmaceuticals USA, Inc. | 102 | $1,224 |
| Johnson & Johnson | 44 | $818 |
| Alkermes, Inc. | 36 | $675 |
| Lundbeck LLC | 33 | $625 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $581 |
| Sunovion Pharmaceuticals Inc. | 46 | $493 |
| E.r. Squibb & Sons, L.L.C. | 18 | $464 |
| Neurocrine Biosciences, Inc. | 20 | $440 |
| Indivior Inc. | 18 | $427 |
| Axsome Therapeutics, Inc. | 16 | $361 |
| Vanda Pharmaceuticals Inc. | 15 | $329 |
| Almatica Pharma LLC | 15 | $323 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $177 |
| Viiv Healthcare Company | 1 | $29 |
| Ironshore Pharmaceuticals Inc. | 2 | $28 |
| Tonix Medicines, Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $24 |
| Braeburn Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$447
How this compares
$10,916 in reported general payments places this provider in the 85th percentile of 2,059 psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 161 | $227,272 |
| RexultiBrexpiprazole | 143 | $213,442 |
| Austedo XrDeutetrabenazine | 17 | $206,718 |
| Aripiprazole | 505 | $95,096 |
| Quetiapine Fumarate | 682 | $15,713 |
| Clozapine | 91 | $13,220 |
| Risperdal ConstaRisperidone Microspheres | 11 | $12,978 |
| NamzaricMemantine Hcl/Donepezil Hcl | 21 | $12,611 |
| BelsomraSuvorexant | 27 | $12,472 |
| Olanzapine | 275 | $11,712 |
| Clonazepam | 1,490 | $8,721 |
| Mirtazapine | 653 | $7,407 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 94 | $6,167 |
| Duloxetine Hcl | 504 | $6,121 |
| Bupropion XlBupropion Hcl | 402 | $6,057 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Namzaric, Viibryd | $2,420 | $244,098195 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,368 | $213,442143 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,224 | $206,71817 claims |
| Johnson & JohnsonRisperdal Consta | $818 | $12,97811 claims |
| Almatica Pharma LLCSertraline Hcl | $323 | $1,654564 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Coral Gables
- Moraima TrujilloCoral Gables$6.6M
- Ilan MelnickCoral Gables$2.8M
- Yesenia KuanCoral Gables$2.1M
- Evelyn Lopez-BrignoniCoral Gables$2M
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.